Schizophrenia

ABC News - Jan 13th, 2025
Score 6.8

J&J buys Intra-Cellular in $14.6B deal, delving into central nervous system disorders

J&J acquires Intra-Cellular Therapies for $14B to boost CNS treatment portfolio

Previous Next

Showing 1 to 1 of 1 results